Liquid Biopsy in Lung Cancer

Samsung Medical Center

Status: Completed

Conditions: Lung Cancer (Diagnosis); Circulating Tumor Cell

Study type: Observational

Funder types: Other

Identifiers

NCT03479099

2018-01-081

Details and patient eligibility

About

The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.

Full description

The peripheral blood and tumor tissue samples are collected from the participants.CTC and ctDNA are analyzed from the blood samples.

Enrollment: 111 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with histology-proven lung cancer or a clinical suspicion of lung cancer
• Age >=18, < 80 years
• No previous history of cancer treatment within 5 years
• Patients who agree to participate

Exclusion criteria

• Patients who have been diagnosed with malignancy within 5 years
• Patients with previous history of lung cancer
• Patients who have uncontrolled coagulopathy